Advocacy

Here you will find a collection of position papers and specific guidance from the Association of Cannabinoid Specialists.

Federal_framework.png

 

While a patchwork of state cannabis laws exists, the lack of a unified, federal framework regulating medical cannabis places patients at risk, and undermines the relationships that doctors must maintain to ensure an effective and safe treatment paradigm.  Such a framework is both overdue and sorely needed for safe, optimized care of patients across the country. 

Read more
 

Position Papers:

   

blue bullet

ACS Expectations of CME Requirements for Cannabis Specialists

blue bullet

ACS Guidance for Dispensaries
Blue_bullet.png Why A Medical Cannabis System Is More Important Than Ever
blue bullet ACS Guidance on Driving as a Medical Cannabis Patient 
blue bullet

Prescription Vs. Recommendation
   

 

Specific Guidance:

   
blue bullet ACS Response to Congressional RFI on Regulation of CBD and Derivatives 
blue bullet ACS and ASA Comments on Senator Schumer’s Cannabis Opportunity and Administration Act
Blue_bullet.png ACS and MSNJ Letter to Attorney General Merrick Garland
blue bullet ACS Letter To ONDCP Director Rahul Gupta
blue bullet ACS Takes Issue with Wall Street Journal Advertisement
blue bullet ACS Guidance to CDC on Pain Management
blue bullet ACS – MCRAA Joint Comments on FDA Proposed Research Guidelines
blue bullet ACS Joint Amicus Brief to Supreme Court of Pennsylvania
blue bullet ACS Response to Oil (Vape) Pen Ban
blue bullet ACS Response to JAMA article entitled Most Doctors Know Nothing About Cannabis
blue bullet ACS Guidance to Massachusetts on Veteran Care
Blue_bullet.png ACS Guidance to Hawaii on Anxiety Treatment
   

 

We also agree with the position for the following groups:

 

American Heart Association Statement on Cannabis

American College of Obstetricians and Gynecologists Statement on Cannabis During Pregnancy and Lactation